Imatinib, the active component of Veenat pills, has a 400mg dosage. A tyrosine kinase inhibitor called imatinib is used to treat specific cancers. It is typically recommended for gastrointestinal stromal tumours (GISTs) and chronic myeloid leukaemia (CML).
Imatinib functions by inhibiting particular proteins that, particularly in tumours with particular genetic abnormalities, encourage the growth and division of cancer cells.
To manage any adverse effects and guarantee the best possible treatment results, regular medical monitoring is required. Under the supervision of a licenced healthcare practitioner, Veenat should be utilised.
Veenat may result in side effects, just like other medicine. Skin rashes, muscle cramps, nausea, vomiting, and diarrhoea are examples of frequent adverse effects. During the course of their Veenat treatment, patients should instantly notify their healthcare practitioner of any worrying symptoms or side effects. To manage potential adverse effects and maximise therapy effectiveness, routine blood tests and medical monitoring are required.
WHAT IS VEENAT 400MG TABLETS?
Imatinib is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.
WHAT IS THE USE OF VEENAT 400MG TABLETS?
Veenat is used for treating certain types of leukemia, certain bone marrow diseases, a certain type of skin cancer, and certain intestinal tumors (eg, gastrointestinal stromal tumors [GIST]). It may also be used to prevent cancer from growing in patients after surgical removal of GIST.